 RTT News |
Asthma Drug May Treat Chronic Hive Sufferers
RTT News Xolair (omalizumab), a drug used to treat sufferers of severe allergies by injections, has completed Phase III of its trial period, and now awaits approval by the FDA. Results of the test were published in The New England Journal of Medicine (February 25). |
View full post on asthma – Google News